Outside San Diego, Illumina Looks to Wisconsin for Key R&D
Summary
But this situation doesn’t always play out, and Nick Caruccio is glad that’s not what happened to his company, Madison, WI-based Epicentre, after San Diego-based Illumina (NASDAQ: ILMN) bought it in 2011 for an undisclosed price.Epicentre, founded in 1987, was a privately held company that had built a solid but unsexy business, primarily selling specialty enzymes and reagents to molecular biology researchers.About five years ago, it started developing prep kits that convert DNA or RNA samples into “libraries” ready to be sequenced by machines made by Illumina and its competitors.Pasadena, CA-based Arrowhead set up its main R&D team in Madison a couple years ago, out of the ashes of the former Mirus Bio, which Roche bought in 2008 for $125 million but divested in 2011 after it decided to get out of the RNAi game.“These industries certainly are changing rapidly all the time, but again, we seem to be able to have some talent that’s been able to adapt and have relevance for the larger company,” says Greg Hyer, interim director of Madison’s University Research Park.